Merck Licenses Kelun-Biotech ADC’s in Deal Worth $9.3 Billion January 4, 2023 AutoBot News 0 Merck, known as MSD outside of the United States and Canada, will pay Kelun-Biotech up to $9l3 billion for seven early-stage oncology treatments.
